1	AM580	AM580	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	stable	stable	_	_	_	_	_	_	_
5	benzoic	benzoic	_	_	_	_	_	_	_
6	derivative	derivative	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	retinoic	retinoic	_	_	_	_	_	_	_
9	acid	acid	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	has	have	_	_	_	_	_	_	_
12	powerful	powerful	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	selective	selective	_	_	_	_	_	_	_
15	cyto-differentiating	cyto-differentiating	_	_	_	_	_	_	_
16	effects	effect	_	_	_	_	_	_	_
17	on	on	_	_	_	_	_	_	_
18	acute	acute	_	_	_	_	_	_	_
19	promyelocytic	promyelocytic	_	_	_	_	_	_	_
20	leukemia	leukemia	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	All-trans	all-trans	_	_	_	_	_	_	_
2	retinoic	retinoic	_	_	_	_	_	_	_
3	acid	acid	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	ATRA	ATRA	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	successfully	successfully	_	_	_	_	_	_	_
9	used	use	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cyto-differentiating	cyto-differentiating	_	_	_	_	_	_	_
13	treatment	treatment	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	acute	acute	_	_	_	_	_	_	_
16	promyelocytic	promyelocytic	_	_	_	_	_	_	_
17	leukemia	leukemia	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	APL	APL	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Paradoxically	paradoxically	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	APL	APL	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	express	express	_	_	_	_	_	_	_
6	PML-RAR	PML-RAR	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	aberrant	aberrant	_	_	_	_	_	_	_
10	form	form	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	retinoic	retinoic	_	_	_	_	_	_	_
14	acid	acid	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	type	type	_	_	_	_	_	_	_
17	alpha	alpha	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	RAR	RAR	_	_	_	_	_	_	_
20	alpha	alpha	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	derived	derive	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	leukemia-specific	leukemia-specific	_	_	_	_	_	_	_
26	t(15;17)	t(15;17)	_	_	_	_	_	_	_
27	chromosomal	chromosomal	_	_	_	_	_	_	_
28	translocation	translocation	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	here	here	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	AM580	AM580	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	stable	stable	_	_	_	_	_	_	_
9	retinobenzoic	retinobenzoic	_	_	_	_	_	_	_
10	derivative	derivative	_	_	_	_	_	_	_
11	originally	originally	_	_	_	_	_	_	_
12	synthesized	synthesize	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	RAR	RAR	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	agonist	agonist	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	powerful	powerful	_	_	_	_	_	_	_
22	inducer	inducer	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	granulocytic	granulocytic	_	_	_	_	_	_	_
25	maturation	maturation	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	NB4	NB4	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	an	an	_	_	_	_	_	_	_
30	APL-derived	apl-derived	_	_	_	_	_	_	_
31	cell	cell	_	_	_	_	_	_	_
32	line	line	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	freshly	freshly	_	_	_	_	_	_	_
37	isolated	isolate	_	_	_	_	_	_	_
38	APL	APL	_	_	_	_	_	_	_
39	blasts	blast	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	After	after	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	APL	APL	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	AM580	am580	_	_	_	_	_	_	_
8	either	either	_	_	_	_	_	_	_
9	alone	alone	_	_	_	_	_	_	_
10	or	or	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	combination	combination	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	granulocyte	granulocyte	_	_	_	_	_	_	_
15	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
16	factor	factor	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	G-CSF	G-CSF	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	compound	compound	_	_	_	_	_	_	_
23	induces	induce	_	_	_	_	_	_	_
24	granulocytic	granulocytic	_	_	_	_	_	_	_
25	maturation	maturation	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	as	as	_	_	_	_	_	_	_
28	assessed	assess	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	determination	determination	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	levels	level	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	leukocyte	leukocyte	_	_	_	_	_	_	_
36	alkaline	alkaline	_	_	_	_	_	_	_
37	phosphatase	phosphatase	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	CD11b	CD11b	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	CD33	CD33	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	and	and	_	_	_	_	_	_	_
44	G-CSF	G-CSF	_	_	_	_	_	_	_
45	receptor	receptor	_	_	_	_	_	_	_
46	mRNA	mRNA	_	_	_	_	_	_	_
47	,	,	_	_	_	_	_	_	_
48	at	at	_	_	_	_	_	_	_
49	concentrations	concentration	_	_	_	_	_	_	_
50	that	that	_	_	_	_	_	_	_
51	are	be	_	_	_	_	_	_	_
52	10-	10-	_	_	_	_	_	_	_
53	to	to	_	_	_	_	_	_	_
54	100-fold	100-fold	_	_	_	_	_	_	_
55	lower	low	_	_	_	_	_	_	_
56	than	than	_	_	_	_	_	_	_
57	those	those	_	_	_	_	_	_	_
58	of	of	_	_	_	_	_	_	_
59	ATRA	ATRA	_	_	_	_	_	_	_
60	necessary	necessary	_	_	_	_	_	_	_
61	to	to	_	_	_	_	_	_	_
62	produce	produce	_	_	_	_	_	_	_
63	similar	similar	_	_	_	_	_	_	_
64	effects	effect	_	_	_	_	_	_	_
65	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	AM580	AM580	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	not	not	_	_	_	_	_	_	_
7	effective	effective	_	_	_	_	_	_	_
8	as	as	_	_	_	_	_	_	_
9	ATRA	ATRA	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	modulating	modulate	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	these	these	_	_	_	_	_	_	_
16	differentiation	differentiation	_	_	_	_	_	_	_
17	markers	marker	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	HL-60	HL-60	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	line	line	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	freshly	freshly	_	_	_	_	_	_	_
26	isolated	isolate	_	_	_	_	_	_	_
27	granulocytes	granulocyte	_	_	_	_	_	_	_
28	obtained	obtain	_	_	_	_	_	_	_
29	from	from	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	peripheral	peripheral	_	_	_	_	_	_	_
32	blood	blood	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	chronic	chronic	_	_	_	_	_	_	_
35	myelogenous	myelogenous	_	_	_	_	_	_	_
36	leukemia	leukemia	_	_	_	_	_	_	_
37	patients	patient	_	_	_	_	_	_	_
38	during	during	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	stable	stable	_	_	_	_	_	_	_
41	phase	phase	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	the	the	_	_	_	_	_	_	_
44	disease	disease	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	NB4	nb4	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	two	two	_	_	_	_	_	_	_
6	other	other	_	_	_	_	_	_	_
7	synthetic	synthetic	_	_	_	_	_	_	_
8	nonselective	nonselective	_	_	_	_	_	_	_
9	RAR	rar	_	_	_	_	_	_	_
10	ligands	ligand	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	capable	capable	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	inducing	induce	_	_	_	_	_	_	_
15	LAP	LAP	_	_	_	_	_	_	_
16	as	as	_	_	_	_	_	_	_
17	much	much	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	AM580	AM580	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	whereas	whereas	_	_	_	_	_	_	_
22	RAR	rar	_	_	_	_	_	_	_
23	beta-	beta-	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	RAR	rar	_	_	_	_	_	_	_
26	gamma-specific	gamma-specific	_	_	_	_	_	_	_
27	ligands	ligand	_	_	_	_	_	_	_
28	are	be	_	_	_	_	_	_	_
29	totally	totally	_	_	_	_	_	_	_
30	ineffective	ineffective	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	AM580	am580	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	more	more	_	_	_	_	_	_	_
8	powerful	powerful	_	_	_	_	_	_	_
9	than	than	_	_	_	_	_	_	_
10	ATRA	ATRA	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	modulating	modulate	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	differentiation	differentiation	_	_	_	_	_	_	_
17	antigens	antigen	_	_	_	_	_	_	_
18	only	only	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	which	which	_	_	_	_	_	_	_
23	PML-RAR	PML-RAR	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	present	present	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	experiments	experiment	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	using	use	_	_	_	_	_	_	_
5	COS-7	cos-7	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	transiently	transiently	_	_	_	_	_	_	_
8	transfected	transfecte	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	PML-RAR	PML-RAR	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	normal	normal	_	_	_	_	_	_	_
14	RAR	rar	_	_	_	_	_	_	_
15	alpha	alpha	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	show	show	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	AM580	AM580	_	_	_	_	_	_	_
20	has	have	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	lower	low	_	_	_	_	_	_	_
23	affinity	affinity	_	_	_	_	_	_	_
24	than	than	_	_	_	_	_	_	_
25	ATRA	ATRA	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	both	both	_	_	_	_	_	_	_
28	receptors	receptor	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	presence	presence	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	PML-RAR	PML-RAR	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	synthetic	synthetic	_	_	_	_	_	_	_
11	retinoid	retinoid	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	much	much	_	_	_	_	_	_	_
15	better	good	_	_	_	_	_	_	_
16	transactivator	transactivator	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	retinoic	retinoic	_	_	_	_	_	_	_
19	acid-responsive	acid-responsive	_	_	_	_	_	_	_
20	element-containing	element-containing	_	_	_	_	_	_	_
21	promoters	promoter	_	_	_	_	_	_	_
22	than	than	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	natural	natural	_	_	_	_	_	_	_
25	retinoid	retinoid	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	whereas	whereas	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	presence	presence	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	RAR	RAR	_	_	_	_	_	_	_
34	alpha	alpha	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	AM580	AM580	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	ATRA	ATRA	_	_	_	_	_	_	_
39	have	have	_	_	_	_	_	_	_
40	similar	similar	_	_	_	_	_	_	_
41	activity	activity	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	may	may	_	_	_	_	_	_	_
3	explain	explain	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	strong	strong	_	_	_	_	_	_	_
6	cyto-differentiating	cyto-differentiating	_	_	_	_	_	_	_
7	potential	potential	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	AM580	am580	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	PML-RAR-containing	pml-rar-containing	_	_	_	_	_	_	_
12	leukemic	leukemic	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

